Over the last period, Agilent Technologies, Inc. has seen a significant fluctuation in stock transaction activity. Several investment firms, including Grant Private Wealth Management Inc, ExodusPoint Capital Management LP, and Univest Financial Corp, have increased their stakes in Agilent. Simultaneously, Arrowstreet Capital Limited Partnership and California Public Employees Retirement System were among those that reduced their holdings. The company also witnessed a number of insider transactions. Director Daniel Podolsky sold $211,844 worth of stock, while other insiders also recorded significant sales. In other major developments, a board member resigned in between declining share prices. Despite hitting a new 1-year low following insider selling, Agilent was picked as a top choice for retirement portfolios. The company announced unveiling new digital pathology tools and adjusted its price target from $140 to $132. Its recent performance led to views that recent price weakness makes the stock a buy, even though stock fell after cautious views for 2025. A collaboration with ABB was announced and the company's spectrometer received honors. Nonetheless, amidst these developments, its stock hit a 52-week low of $119.32 amid market challenges.
Agilent Technologies A News Analytics from Tue, 30 Jul 2024 07:00:00 GMT to Sat, 05 Apr 2025 11:09:58 GMT - Rating 1 - Innovation 3 - Information 4 - Rumor -2
